Prioritizing Comparative Effectiveness Research Questions for the Treatment of Multiple Sclerosis: A Stakeholder Workshop

PCORI hosted a multi-stakeholder workshop in Washington, D.C., to discuss whether comparative clinical effectiveness research (CER) can help to answer questions surrounding treatment of Multiple Sclerosis.

In-person attendance was by invitation only but the public was welcome to listen in via teleconference and webinar. We invited representatives of a wide range of stakeholder groups, including patients, caregivers, clinicians, industry, payers, and researchers to participate in the discussion.

Meeting Materials

• Agenda
• Participants List
• Topic Brief
• Submitted Breakout Group Topics and Questions
• Presentation Slides
• Meeting Summary

Teleconference Audio Recordings

• General Session: Listen to the session recording
• Breakout Session 1 (Comparison of DMTs, including differential effects in subgroups): Listen to the session recording
• Breakout Session 2 (Care strategies): Listen to the session recording
• Breakout Session 3 (Non-pharmacologic therapy for specific symptoms and overall health): Listen to the session recording
• Breakout Session 4 (Timing of therapy and study design): Listen to the session recording